Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Item | Description | The company |
---|---|---|
EBITDA | To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. | CVS Health Corp. EBITDA increased from 2022 to 2023 but then slightly decreased from 2023 to 2024 not reaching 2022 level. |
Enterprise Value to EBITDA Ratio, Current
Selected Financial Data (US$ in millions) | |
Enterprise value (EV) | 137,966) |
Earnings before interest, tax, depreciation and amortization (EBITDA) | 13,703) |
Valuation Ratio | |
EV/EBITDA | 10.07 |
Benchmarks | |
EV/EBITDA, Competitors1 | |
Abbott Laboratories | 21.77 |
Elevance Health Inc. | 8.65 |
Intuitive Surgical Inc. | 53.20 |
Medtronic PLC | 15.13 |
UnitedHealth Group Inc. | 15.82 |
EV/EBITDA, Sector | |
Health Care Equipment & Services | 16.11 |
EV/EBITDA, Industry | |
Health Care | 19.08 |
Based on: 10-K (reporting date: 2024-12-31).
1 Click competitor name to see calculations.
If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.
Enterprise Value to EBITDA Ratio, Historical
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Enterprise value (EV)1 | 135,154) | 146,035) | 151,066) | 181,495) | 146,595) | |
Earnings before interest, tax, depreciation and amortization (EBITDA)2 | 13,703) | 18,197) | 12,162) | 17,435) | 17,118) | |
Valuation Ratio | ||||||
EV/EBITDA3 | 9.86 | 8.03 | 12.42 | 10.41 | 8.56 | |
Benchmarks | ||||||
EV/EBITDA, Competitors4 | ||||||
Abbott Laboratories | 22.28 | 19.49 | 15.85 | 17.42 | 25.99 | |
Elevance Health Inc. | 8.15 | 10.24 | 10.26 | 10.05 | 7.57 | |
Intuitive Surgical Inc. | 63.79 | 53.82 | 41.52 | 44.54 | 59.12 | |
Medtronic PLC | 14.63 | 15.28 | 14.99 | 24.41 | 17.92 | |
UnitedHealth Group Inc. | 17.17 | 13.60 | 15.11 | 17.39 | 13.39 | |
EV/EBITDA, Sector | ||||||
Health Care Equipment & Services | 16.98 | 14.01 | 14.82 | 16.32 | 14.62 | |
EV/EBITDA, Industry | ||||||
Health Care | 20.34 | 19.28 | 13.93 | 14.07 | 17.33 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
3 2024 Calculation
EV/EBITDA = EV ÷ EBITDA
= 135,154 ÷ 13,703 = 9.86
4 Click competitor name to see calculations.
Valuation ratio | Description | The company |
---|---|---|
EV/EBITDA | Enterprise value to earnings before interest, tax, depreciation and amortization is a valuation indicator for the overall company rather than common stock. | CVS Health Corp. EV/EBITDA ratio decreased from 2022 to 2023 but then slightly increased from 2023 to 2024. |